| CAS ID: | 229016-73-3 |
| Molecular Formula: | C22H21N8O8PS4 |
| Molecular Weight: | 684.7 g/mol |
| Monoisotopic Mass: | 684.0103 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PPI-0903 | TAK 599 | CEFTAROLINE FOSAMIL ACETATE | TEFLARO | CEFTAROLINE FOSAMIL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1 | See All |
| InChI Key: | ZCCUWMICIWSJIX-NQJJCJBVSA-N | |
| Smiles: | CCO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)[O-])Sc3nc(cs3)c4cc[n+](C)cc4)\c5nsc(NP(=O)(O)O)n5 | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 26748559 | Target ID | |
| Uniprot ID | Name | ||
| Model | human | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
| PubChem: | 57514685 |
| ChEMBL: | CHEMBL501122 |